Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Grothey

Showing results (211-220 of 304) with videos related to

Pageof 31
Sort By:
Cancer Causes & Control : CCC|May 20, 2019
Influence of genetic variation in the vitamin D pathway on plasma 25-hydroxyvitamin D<sub>3</sub> levels and survival among patients with metastatic colorectal cancerChen Yuan, Lindsay Renfro, Pratibha B Ambadwar, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2023
Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancerMichel Ducreux, Josep Tabernero, Axel Grothey, et al.
The Oncologist|September 30, 2016
Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal CancerAndrew Rankin, Samuel J Klempner, Rachel Erlich, et al.
BMJ Open|September 25, 2021
BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancerPashtoon Murtaza Kasi, Sarah Sawyer, Jessica Guilford, et al.
The Oncologist|November 25, 2016
Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)Preet Paul Singh, Qian Shi, Nathan R Foster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trialsDaniel Sargent, Alberto Sobrero, Axel Grothey, et al.
Molecular Cancer Research : MCR|March 11, 2018
Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal CancersMohamed E Salem, Alberto Puccini, Axel Grothey, et al.
Cancer|June 15, 2007
Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancerAmanda C Ashley, Daniel J Sargent, Steven R Alberts, et al.
International Journal of Cancer|May 26, 2020
Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumorsMohamed E Salem, J Nicholas Bodor, Alberto Puccini, et al.
ESMO Open|May 2, 2018
Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data setAxel Grothey, Takayuki Yoshino, Gyorgy Bodoky, et al.
Pageof 31

Showing results (211-220 of 304) with videos related to

Sort By:
Pageof 31
Cancer Causes & Control : CCC|May 20, 2019
Influence of genetic variation in the vitamin D pathway on plasma 25-hydroxyvitamin D<sub>3</sub> levels and survival among patients with metastatic colorectal cancerChen Yuan, Lindsay Renfro, Pratibha B Ambadwar, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2023
Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancerMichel Ducreux, Josep Tabernero, Axel Grothey, et al.
The Oncologist|September 30, 2016
Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal CancerAndrew Rankin, Samuel J Klempner, Rachel Erlich, et al.
BMJ Open|September 25, 2021
BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancerPashtoon Murtaza Kasi, Sarah Sawyer, Jessica Guilford, et al.
The Oncologist|November 25, 2016
Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)Preet Paul Singh, Qian Shi, Nathan R Foster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trialsDaniel Sargent, Alberto Sobrero, Axel Grothey, et al.
Molecular Cancer Research : MCR|March 11, 2018
Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal CancersMohamed E Salem, Alberto Puccini, Axel Grothey, et al.
Cancer|June 15, 2007
Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancerAmanda C Ashley, Daniel J Sargent, Steven R Alberts, et al.
International Journal of Cancer|May 26, 2020
Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumorsMohamed E Salem, J Nicholas Bodor, Alberto Puccini, et al.
ESMO Open|May 2, 2018
Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data setAxel Grothey, Takayuki Yoshino, Gyorgy Bodoky, et al.
Pageof 31